In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
Offering improved functionality of existing radiology information systems (RIS), a new partnership between RamSoft and Alpha Nodus may significantly enhance radiology workflow and address the time-consuming nature of prior authorizations.
RamSoft said the integration of the Gravity AI (Alpha Nodus) tools into its RIS offerings will streamline radiology workflows through increased automation. Alpha Nodus maintained that artificial intelligence (AI)-powered automation will reduce the burden of prior authorizations in radiology.
“Prior authorizations once took hours or even days," said Shamit Patel, the CEO of Alpha Nodus. "With Gravity, now integrated into PowerServer, we've fully automated or reduced that to just minutes, improving efficiency and accelerating the patient journey."
The companies said key benefits of the integration will include:
• real-time verification of payer requirements to prevent delays
• AI-enabled patient scheduling to reduce no-shows
• up to a 25 percent reduction of claim denial rates through compliance checks
RamSoft and Alpha Nodus will be showcasing the updated software at the Radiology Business Management Association (RBMA) Paradigm 2025 conference through March 27.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
2 Commerce Drive
Cranbury, NJ 08512